Roche Boasts Of Tecentriq's Broad Potential In 3Q Earnings Update

 
• By Lucie Ellis-Taitt
Quality Quantity
Roche is at a 'unique time for both the quantity and quality of medicines' in its oncology portfolio • Source: Shutterstock

More from Earnings

More from Business